🇺🇸

Broad Market

· monthly

US Pre-Market SEC Filings Roundup — September 16, 2026

Overnight filings reveal a market bifurcated between aggressive insider profit-taking in the energy sector and strategic capital repositioning in financials and healthcare. Key themes include a major refinancing play by Brightstar Lottery (liability management), a significant guidance raise by Oscar Health (operational leverage), and a notable pattern of insider sales at elevated valuations in energy and industrial names. The market is pricing in stability, but the breadth of insider selling and the passive nature of several large stake disclosures warrant a cautious, stock-selective approach.

32 high priority 18 medium 50 total filings
· daily

US Material Events SEC 8-K Filings — September 15, 2026

The September 15, 2026 filing batch reveals a market actively rebalancing capital structures, with significant debt refinancing and capital markets activity (Dell's $5.0B notes, Ares Capital's $750M notes, Axon's $1.0B converts) alongside strategic M&A (Lindblad's $61M White Desert acquisition, Iridium's pending Rocket Lab merger). Leadership transitions are widespread, with notable CEO changes at Otis and Intrusion, and a wave of board appointments bringing AI/defense expertise (Sanmina, Innodata, Gap). Financial stress is evident in several small caps, with Nasdaq delisting threats (Hub Group), board collapses (IIOT-OXYS), and distressed refinancings (CaliberCos), while larger companies execute opportunistic buybacks (Scotts Miracle-Gro $500M, Redwood Trust $20M). Guidance revisions are mixed: Lindblad raised full-year 2026 guidance, while Hub Group projected an operating loss. Insider activity is limited but notable, with FibroBiologics' CSO participating in a private placement and The Trade Desk's CEO receiving a performance-based option. The overall theme is one of strategic repositioning—companies are preparing for growth, managing leverage, and positioning for AI/defense opportunities, but small-cap distress and governance instability warrant caution.

50 high priority 50 total filings
· daily

Global High-Priority Regulatory Events — September 15, 2026

The 40 filings reveal a high-activity period in the US and Indian markets, centered on distressed situations, SPAC/business combinations, and strategic capital actions. Key themes include a wave of delistings and going-concern risks, a flurry of SPAC merger activity, and significant insider and capital allocation moves. Notable trends: margin compression in some growth companies, aggressive buybacks in others, and a mix of regulatory-driven and voluntary delistings. The most critical developments are the Nasdaq delistings of XMAX and the unnamed company (moving to OTCQB), the high-materiality going-concern filing, and the SPAC merger announcements, which present both risks and opportunities.

40 high priority 40 total filings
· daily

US SEC Filings Daily Market Digest — September 15, 2026

Today's SEC filings (Sep 15, 2026) reveal a market bifurcated between aggressive capital deployment and defensive financial management. Grab Holdings' $1.49B acquisition of Atome Financial signals a major push into BNPL/digital financial services, while BHP's record FY2026 results (profit up 8.9% YoY, dividends up 56% YoY) underscore strength in resources. However, multiple late filings (Ingram Micro, two NT 10-Q filers) and a Nasdaq delisting threat for a logistics company highlight compliance stress. Insider activity is mixed—TORM's secondary offering and a CEO reverse split signal dilution, while consistent buybacks (Unilever, daily 210K B shares) show confidence. Sector themes include a shift to shareholder returns (dividends up, buybacks steady), SPAC portfolio risk (SkyView's $127.7M portfolio with many zero-value warrants), and regulatory overhang in financial services. Key catalysts: Grab's acquisition closing, BHP's safety review, and the October 15 shareholder vote for a homebuilder. Overall, opportunities lie in high-growth fintech and resource plays, while risks center on compliance failures and speculative SPAC exposure.

17 high priority 33 medium 50 total filings
· monthly

US Pre-Market SEC Filings Roundup — September 15, 2026

Overnight SEC filings from September 14-15, 2026 reveal a market bifurcated between aggressive capital deployment and mounting operational distress. The most significant themes are a wave of high-value M&A clearing regulatory hurdles (Atkore/Prysmian, Iridium/Rocket Lab), a major fintech expansion by Grab Holdings ($1.49B Atome Financial acquisition), and a concerning cluster of late filings and delisting risks (Hub Group, Maison Solutions, InnSuites Hospitality). Insider activity is dominated by large-scale selling, notably a $54.9M block sale by CPI Card Group's 10% owner and a $9.87M sale by a Chime Financial director, signaling potential valuation concerns in those names. On the positive side, BHP Group reported strong FY2026 results with attributable profit up 8.9% YoY and dividends surging 56.4%, while Equinor and Novo Nordisk continued substantial buyback programs. The period-over-period data from Korea Electric Power Corp shows a clear divergence, with nuclear profits up 28.9% YoY but thermal generation swinging to a loss, highlighting the energy transition's impact on legacy assets. Overall, the digest points to active M&A and capital returns in quality names, offset by operational and compliance stress in smaller, leveraged entities.

29 high priority 21 medium 50 total filings
· daily

US Material Events SEC 8-K Filings — September 14, 2026

The 50 filings reveal a market bifurcated between aggressive capital raises and strategic M&A versus governance and liquidity stress. Key themes include SPAC deal terminations and amendments, insider buying in mining, and a wave of CFO/COO appointments signaling operational focus. Notable outliers include Trilogy Metals' strategic investment and Dexcom's insider buying, while CitroTech's going concern and multiple SPAC failures highlight risks. The period comparisons show margin improvements in some sectors (e.g., North America adjusted EBITDA margin up 940 bps) versus declines in others (International gross margin down 555 bps).

50 high priority 50 total filings
· daily

Global High-Priority Regulatory Events — September 14, 2026

The September 14, 2026, filing batch is dominated by distressed situations and corporate restructuring, with 5 filings signaling severe financial distress (MTNL defaults, CMI Ltd going concern, Cambium Networks subsidiary insolvency) and 3 SPAC-related failures or delays (Embrace Change termination, Future Vision II extension, Hudson Acquisition I cash crunch). On the M&A front, 4 significant transactions closed or were announced: Magnolia Oil & Gas closed its WildFire Energy acquisition, Ondas Holdings acquired GATE Technologies for $205M, Veracyte bought Convergent Genomics for $150M, and the MiniMed spin-off from Medtronic progressed with an exchange offer. A notable theme is the wave of routine debt delistings from major banks (Barclays, Santander, Shell) following maturities, which are non-events operationally. The most actionable insights come from the distressed plays: MTNL's ₹37,475 crore total indebtedness with defaults dating back 18+ months, and Cambium Networks' 53.6% workforce cut without severance alongside a UK administration filing. Period-over-period data was limited to MiniMed's S-4, which showed strong 11.5% revenue growth and 14.5% net income growth, contrasting sharply with the broader distress theme.

30 high priority 30 total filings
· daily

US SEC Filings Daily Market Digest — September 14, 2026

Today's filings reveal a market bifurcated between aggressive capital-raising activity and significant corporate distress signals. SPACs dominate the IPO pipeline with two new blank-check companies filing for a combined $250 million, while biotech IPOs like Electra Therapeutics ($296.6M expected) signal continued appetite for life sciences. However, the day is punctuated by major red flags: Embrace Change Acquisition Corp.'s merger termination leaves it without a target, Apogee Therapeutics' deregistration suggests a full acquisition by AbbVie, and MOBIX LABS faces imminent Nasdaq delisting risk. On the positive side, insider confidence is notable with Oracle's Larry Ellison canceling his stock sale plan and NEONC's CEO buying shares. Period-over-period data from UNFI shows a strong operational turnaround (net income swing of +$202M YoY), while the Skyworks/Qorvo exchange offer extension (over 90% tendered) signals a high-probability merger closure. The day also features a notable insider exit: Toyota fully exited its Grab Holdings position, and a key leadership reshuffle at ZK International raises governance concerns.

15 high priority 35 medium 50 total filings
· monthly

US Pre-Market SEC Filings Roundup — September 14, 2026

Overnight filings reveal a market bifurcated between aggressive capital markets activity and fundamental business stress. The SPAC space shows renewed IPO energy with two new blank-check filings (Eaglesky Acquisition Corp, Leader's Advantage) targeting $250M combined, while Embrace Change Acquisition Corp. faces a failed merger, highlighting the binary outcomes in this sector. Corporate governance is in flux, with leadership changes at VinFast, ZK International, and Woodside Energy, while insider confidence signals are mixed: a bullish CEO purchase at NEONC TECHNOLOGIES contrasts with Larry Ellison's cancelled Oracle sale plan. Financial health indicators are divergent: UNFI posted a strong operational turnaround with a $202M swing to net income, while InPoint Commercial Real Estate cut its distribution and Faraday Future flagged ongoing going-concern risks. The IPO pipeline is active with Electra Therapeutics ($296.6M expected proceeds), Einride AB (EV/autonomous trucking), and Radiopharm Theranostics filing shelf registrations. Sector-wise, healthcare/biotech dominates with multiple clinical trial updates (Clearmind Medicine, Lipocine) and a significant insider stake disclosure (Dr. Phillip Frost in Safe Pro Group). Capital allocation trends show Prudential executing a consistent buyback program while Nomura has paused its repurchases after hitting its monetary cap. The overall tone is cautiously constructive, with capital formation accelerating but underlying operational challenges persisting across several sectors.

15 high priority 35 medium 50 total filings
· daily

US Material Events SEC 8-K Filings — September 11, 2026

The September 11, 2026, material events landscape is dominated by acute financial distress and strategic pivots, with several companies facing existential liquidity crises. America's Car-Mart and Karyopharm Therapeutics are in critical forbearance and restructuring situations, while P3 Health Partners is resorting to a 19.5% preferred stock issuance, signaling severe capital constraints. Conversely, a significant capital market event is the $1.0 billion equity raise by Oklo Inc., which fully exhausted its prior ATM facility, indicating strong investor appetite for high-growth energy stories. The period is also marked by a wave of executive departures, with CFOs resigning at TransCode, Citi Trends, Peraso, and CleanCore, among others, creating operational uncertainty. A notable positive development is the merger of Korsana Biosciences with Cyclerion, backed by a $380 million private placement, providing a substantial cash runway into 2029. The overall theme is a bifurcated market where cash-rich, high-growth companies can access capital easily, while distressed entities face a rapidly closing window for refinancing.

50 high priority 50 total filings
· daily

Global High-Priority Regulatory Events — September 11, 2026

The September 11, 2026 digest reveals a market dominated by significant restructuring and distress events, with a clear bifurcation between successful turnarounds and escalating failures. The most critical development is New Fortress Energy's completion of a massive restructuring that extinguished ~$5.7 billion in debt, representing a landmark event in the energy sector. Insolvency and CIRP resolutions are accelerating, with Diamond Power Infrastructure completing its resolution one year early and VXL Instruments approving a plan that wipes out equity holders. The SPAC market shows extreme stress, with Ribbon Acquisition Corp experiencing a 68.1% redemption rate, while several companies face imminent delisting threats from Nasdaq bid price non-compliance. A concerning pattern of cyber fraud has emerged, with Lancer Container Lines losing ₹53 lakhs in a social engineering attack. Period-over-period trends are limited in these event-driven filings, but the aggregate data shows a clear pattern of distressed companies seeking emergency capital structure solutions through mergers, reverse stock splits, and debt restructuring.

40 high priority 40 total filings
· daily

US SEC Filings Daily Market Digest — September 11, 2026

Today's filings reveal a market bifurcated between operational turnarounds and persistent financial strain. Hooker Furnishings posted a $4.9M swing to profitability driven by tariff recoveries, while LightPath Technologies saw revenue surge 93% YoY yet its net loss widened to $20.5M, highlighting the cost of hypergrowth. The SPAC space remains active with three new business combination filings (Graf Global/BIG3, Research Alliance III/Oak Hill Bio, DTSQ/Primegen), signaling continued appetite for public market debuts despite a mixed macro backdrop. Insider selling at Sea Ltd by three top executives for a combined ~$4.2M under 10b5-1 plans contrasts with a major insider accumulation at Evogene (1.26M shares bought). Debt management is a key theme: Impinj reduced its 2027 notes by $56.3M, while Wynn Resorts added $900M in high-coupon debt (6.875%) and Nauticus Robotics extended $4M in convertible debentures, reflecting divergent credit profiles. The most actionable trend is the convergence of space and biotech in SPAC mergers, alongside a clear signal that companies with tariff or regulatory tailwinds (Hooker, LightPath) are outperforming those with operational headwinds (MoneyHero, Braskem).

21 high priority 29 medium 50 total filings
· monthly

US Pre-Market SEC Filings Roundup — September 11, 2026

The overnight filing set presents a mixed picture for U.S. markets, characterized by significant insider selling at high-growth biotechs and a wave of capital structure changes. A key macro theme is the growing financial strain in the biotechnology sector, with CEOs at Protagonist Therapeutics and Roivant Sciences executing large pre-planned stock sales, while Nauticus Robotics secures a one-year debt extension, signaling ongoing cash burn. Conversely, industrial and technology companies like LightPath Technologies and Descartes Systems Group are reporting robust revenue growth driven by secular tailwinds (defense, supply chain logistics). Notable capital markets activity includes a $1.3 billion dual-tranche debt offering by Thomson Reuters and a $900 million high-yield issuance by Wynn Resorts, contrasting with a $56.5 million debt-for-equity exchange at Impinj. A prominent sector theme is the continued activity in the SPAC market, with several filings advancing de-SPAC mergers with companies in biotech (Oak Hill Bio) and space technology (Gravitics), alongside a proposed public listing of the BIG3 basketball league.

24 high priority 26 medium 50 total filings
· daily

US Material Events SEC 8-K Filings — September 10, 2026

This Material Events Monitor digest covers 50 filings from September 10, 2026, revealing a market landscape defined by aggressive capital deployment through M&A and debt financing, alongside significant corporate restructuring and leadership transitions. The most critical developments include a $1.9B acquisition of ACV Auctions by Copart at a 45% premium, a $200M acquisition of BioCircuit by Axogen, and a $224M deal for Swarmer to acquire Ratel Robotics, signaling a strong appetite for growth through acquisition in the tech-enabled services and defense sectors. However, this is counterbalanced by severe distress signals, including a major restructuring at CVD Equipment (halving its workforce) and a 10.8% revenue decline at 1-800-FLOWERS leading to a goodwill impairment. A notable portfolio-level pattern is the heavy reliance on debt markets for financing, with over $5.4B in new debt issued across just four companies (Williams, Group 1, Autodesk, Public Storage), while insider activity remains largely absent, offering limited conviction signals. The digest identifies a bifurcated market where well-capitalized firms are pursuing aggressive growth, while others are retrenching, restructuring, or facing existential challenges.

50 high priority 50 total filings
· daily

Global High-Priority Regulatory Events — September 10, 2026

This digest covers 25 filings from September 10, 2026, with a heavy concentration on corporate distress and restructuring events. A notable cluster involves three energy infrastructure companies (Sunoco LP, Energy Transfer LP, USA Compression Partners) voluntarily delisting from the NYSE to transfer to the Texas Stock Exchange, signaling a potential trend toward regional exchange migration. The insolvency and bankruptcy theme is prominent, with Shilpa Medicare's subsidiary entering CIRP, VXL Instruments' resolution plan approved with near-total shareholder dilution, and JSW Infrastructure acquiring a loss-making rail company through the IBC process. Several small-cap biotech and tech companies face Nasdaq delisting risks, including 20/20 Biolabs and iSpecimen, both with severe equity deficiencies. On the positive side, Global Interactive Technologies resolved its filing delinquency, and Ryan Cohen continued accumulating GameStop shares. The most significant M&A event is ARC Group Acquisition Corp's $1.09 billion deal to acquire a Malaysian financing company, while SurgePays executed a creative asset sale with a put option to address its Nasdaq compliance issues. Overall, the filings reflect a market environment with high distress among small caps, strategic exchange migrations, and continued SPAC activity.

25 high priority 25 total filings
· monthly

US Pre-Market SEC Filings Roundup — September 10, 2026

Overnight filings reveal a market bifurcated between aggressive capital deployment and insider profit-taking. Axogen's $200M acquisition of BioCircuit Technologies and Indaptus' $24M raise signal continued M&A and financing activity in medtech, while Elevance Health's reaffirmed guidance provides stability in managed care. Insider activity is notably heavy in bitcoin miners (CleanSpark, TeraWulf) and Dell Technologies, where Silver Lake entities are systematically reducing stakes at ~$515-519/share, suggesting potential valuation concerns at current levels. Biohaven's partial clinical hold introduces regulatory overhang in neurology, partially offset by a new licensing deal with SK Biopharmaceuticals. The Equitable-Corebridge merger advances with quantified synergies, while YPF's debt tender offer and H World's $470M bond pricing reflect active liability management. SPAC activity (Elevation Acquisition IPO, XCF Global meeting postponement) and a 22.7% activist stake in Abits Group highlight continued special situations. Overall, the tape is constructive but selective, with capital flowing to growth and consolidation while insiders in high-flying sectors take profits.

34 high priority 16 medium 50 total filings
· daily

US Material Events SEC 8-K Filings — September 09, 2026

The September 9, 2026, filing batch reveals a market actively reshaping itself through M&A, leadership transitions, and strategic capital management. Notable M&A activity includes Diversified Energy's $50M-deposit acquisition of Birch Permian, the Centerspace-Independence Realty Trust all-stock merger creating an $8.1B multifamily REIT, and the completed takeovers of Selectis Health and Barinthus Biotherapeutics. Leadership changes dominate, with CFO appointments at Fortune Brands, Lyft, and Cornerstone Building Brands, and CEO transitions at WW International and electroCore, signaling a broad executive refresh across sectors. Financially, Signet Jewelers stands out with raised full-year EPS guidance and a $700M buyback authorization, while Hallmark Venture Group's restatement and Glucotrack's settlement highlight ongoing financial distress. The period-over-period data shows mixed performance, with Signet's same-store sales growth of 2.2% contrasting with flat total sales, and the market is pricing in both growth optimism (e.g., Joby Aviation, Lexaria) and caution (e.g., Wrap Technologies' performance-based vesting). Overall, the digest points to a market favoring strategic consolidation, operational efficiency, and shareholder returns, with a clear undercurrent of risk in companies with governance or financial reporting issues.

50 high priority 50 total filings
· daily

Global High-Priority Regulatory Events — September 09, 2026

The September 9, 2026 batch is dominated by a wave of SEBI recovery certificate corrigenda (8 filings) and Indian insolvency proceedings, creating a distinctly bearish regulatory and restructuring undercurrent. However, several high-value M&A events—the definitive buyout of Selectis Health, the SPAC merger filings for Daedalus/HubX and Blue Laser Fusion, and the completion of Barinthus Biotherapeutics' acquisition—provide clear positive catalysts. A critical portfolio-level insight emerges from the troubled Indian companies: the financial distress is not uniform, as Oswal Overseas' successful CIRP withdrawal at a 100% creditor vote contrasts sharply with Raja Bahadur International's worsening liquidity crisis (current liabilities 4x current assets) and contradictory public statements. The Barinthus delisting (Voluntary, post-acquisition) and TMC warrant expiration are procedurally neutral, while Iveda Solutions' second Nasdaq extension highlights a binary survival risk for micro-cap companies.

24 high priority 24 total filings
· daily

US SEC Filings Daily Market Digest — September 09, 2026

Today's digest reveals a bifurcated market with strong capital expenditure and M&A activity in industrial and energy sectors, contrasted by significant distress in small-cap and micro-cap companies. Key themes include a wave of transformative M&A in the REIT and biotech spaces, with the $8.1B IRT/Centerspace merger and the $2.5B Standard BioTools/Treeline deal highlighting a trend toward consolidation for scale and pipeline depth. Period-over-period data shows a clear divergence: large-cap industrials like Sunbelt Rentals (+11.2% revenue) and semiconductor firms like ASE Technology (+45.7% YoY) are posting robust growth, while several small-cap firms (C3.ai, GIVBUX, Destination XL) are experiencing revenue declines and cash burn. Insider activity is mixed, with a notable insider purchase at CarParts.com signaling confidence, while CEO selling at SentinelOne and a tax-related sale at Innovex warrant monitoring. The most critical developments include a major accounting restatement at Hallmark Venture Group, a going-private transaction for Selectis Health, and a potential Nasdaq delisting for Premium Catering, all of which demand immediate investor attention.

25 high priority 25 medium 50 total filings
· monthly

US Pre-Market SEC Filings Roundup — September 09, 2026

The overnight filing cycle from September 8-9, 2026, reveals a market dominated by significant insider selling, particularly concentrated in the technology sector, where Silver Lake entities executed a coordinated, multi-faceted sell-down of Dell Technologies Inc. shares totaling over $36 million across multiple filings. This aggressive disposition by a major director, combined with substantial sales at Cloudflare and Sandisk, signals potential sector rotation or profit-taking by sophisticated investors. Conversely, a notable insider buy at Enovis Corp and a director purchase at ASTROTECH Corp provide isolated bullish signals. The period also features transformative corporate actions, including the full acquisition of Selectis Health at a 90.93% tender success rate and the proposed de-SPAC merger of General Fusion with Spring Valley Acquisition Corp. III, alongside a high-risk delisting notice for Premium Catering. Financially, ASE Technology Holding Co., Ltd. reported exceptional growth with revenues surging 45.7% YoY, while VolitionRx faces severe dilution risks from covenant breaches and down-round adjustments. The overall sentiment is cautious, with a clear theme of cash extraction by insiders and a focus on capital returns through buybacks at Novo Nordisk and KT Corp.

35 high priority 15 medium 50 total filings